Here’s hoping that omicron turns out to be little worse than a cold. It has been detected in 38 countries and many US states, but no deaths reported yet–and we know the fearmongers are looking for deaths.
As others have said, and I also thought: wouldn’t it be great if this is a mild strain and we all just need to get it in the expectation it provides some cross immunity for the strains causing more severe illness. Wouldn’t that be nice? But we still need to know whether it causes the severe late sequellae of SARS-2.
Look at all the new mutations and their locations. Look how quickly it spreads:
Are the travel restrictions and lockdowns being imposed so we don’t all catch a mild case and thereby obtain some immunity?
It does look like it came from a lab. Did it fall? Or was it pushed?
Dr. Malone points out that the preliminary data available suggest that this strain can defeat both recovered immunity and vaccine-induced immunity. So let’s hope it mainly causes a cold. Be aware that cases of Covid that occur in the recovered have generally been mild. From the Guardian:
“The Omicron variant has been detected in at least 38 countries but no deaths have yet been reported, the World Health Organization has said, amid warnings that it could damage the global economic recovery.
The United States and Australia became the latest countries to confirm locally transmitted cases of the variant, as Omicron infections pushed South Africa’s total cases past 3 million.
The WHO has warned it could take weeks to determine how infectious the variant is, whether it causes more severe illness and how effective treatments and vaccines are against it…
The new variant could also slow global economic recovery, just as the Delta strain did, the International Monetary Fund chief, Kristalina Georgieva, said on Friday.
“Even before the arrival of this new variant, we were concerned that the recovery, while it continues, is losing somewhat momentum,” she said. “A new variant that may spread very rapidly can dent confidence.”
A preliminary study by researchers in South Africa, where the variant was first reported on 24 November, suggests it is three times more likely to cause reinfections compared with the Delta or Beta strains…“